The trademark application OSE-CYTOMASK was filed by OSE Immunotherapeutics, a corporation established under the laws of the French Republic (the "Applicant"). The application was published for oppositions on September 17, 2023, and it was registered by office on December 25, 2023 without any oppositions.
The application was filed in French (English was selected as the second language).
Goods And Services
The mark was filed in class 5 with following description of goods:
Pharmaceuticals
Sanitary preparations for medical purposes
Dietetic food and substances adapted for medical use
Medicines for human purposes
Chemical preparations for medical or pharmaceutical purposes
Vaccines
Serums
Substances for medicinal purposes
Chemical reagents for medical use
Pharmaceutical preparations for the treatment of autoimmune diseases
Immunostimulants
Immunomodulators
Immunoassay reagents for medical use
Biological preparations for the treatment of cancer
Biotechnological preparations for medical use
Antibodies.
The mark was filed in class 42 with following description of goods:
Scientific and technological services and research and design relating thereto in the field of medicine and health
Design and development of software and data bases
Medical research
Biological research, Biotechnology
Pharmaceutical research services
Clinical studies (clinical trials)
Research and development services in the field of immunology
Research and development in the field of microorganisms, cells and antibodies
Research and development of vaccines and medicines
Biological analysis
Biological laboratory services
Consultancy relating to research and development in the field of therapeutics
Laboratory services relating to the production of monoclonal antibodies
Research and development services in the field of antibodies.
The mark was filed in class 44 with following description of goods: